Validated stability-indicating HPLC-DAD method for determination of the phosphodiesterase (PDE-4) inhibitor roflumilast
A comprehensive stability indicating HPLC with diode array detection method was developed for determination of the recently approved phosphodiesterase type 4 (PDE-4) inhibitor roflumilast (RFL). Effective chromatographic separation was achieved using Durashell C18 column (4.6 × 250 mm, 5 μm particle...
Saved in:
Main Authors: | Tarek S. Belal (Author), Hytham M. Ahmed (Author), Mohamed S. Mahrous (Author), Hoda G. Daabees (Author), Mostafa M. Baker (Author) |
---|---|
Format: | Book |
Published: |
Faculty of Pharmacy, Cairo University,
2014-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HPLC-DAD stability indicating determination of nizatidine in bulk and capsules dosage form
by: Tarek S. Belal, et al.
Published: (2013) -
Roflumilast: Review of Phosphodiesterase-4 Inhibitor as Asthma Therapy
by: Rafina Syfridiana, et al.
Published: (2021) -
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
by: Mark A Giembycz, et al.
Published: (2010) -
Stability-indicating HPLC-DAD method for the determination of empagliflozin
by: Shilpi Pathak, et al.
Published: (2021) -
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
by: Jonathan E. Phillips
Published: (2020)